Osteoarthritis of the hip joints: possibilities of local therapy
https://doi.org/10.21518/ms2023-407
Abstract
Osteoarthritis of the hip joints is one of the most common pathology of the musculoskeletal system. The issues of its therapy are discussed in all clinical recommendations and recently more and more attention has been paid to the introduction of hyaluronic acid preparations. In the Russian recommendations for the treatment of coxarthrosis, this recommendation has a high level of credibility and evidence and is based on a significant number of studies confirming the safety and effectiveness of this therapy in the long term. The article provides data from some studies, as well as the conclusions of the European Consensus Group on intra-articular administration of hyaluronic acid, which prescribes indications and contraindications for the introduction of drugs into the hip joints. The issue of choosing a specific drug among a variety of forms is also discussed and a clinical example of the administration of hyaluronic acid to a patient with osteoarthritis of the hip joints under ultrasound control is considered. A detailed technique of drug administration is described. When considering this clinical example, the good tolerability of the drug, the accuracy of the administration of the drug, as well as the long-term results of the safety and effectiveness of therapy in the form of pain reduction and the absence of the need for NSAIDs are demonstrated.
About the Authors
Yu. S. Filatova
Yaroslavl State Medical University; Center for Diagnostics and Prevention Plus
Russian Federation
Russian Federation
Yulia S. Filatova - Cand. Sci. (Med.), Associate Professor of the Department of Therapy named after E.N. Dormidontov, Institute of Continuing Professional Education, Yaroslavl State Medical University; Rheumatologist, Center for Diagnostics and Prevention Plus.
5, Revolutsionnaya St., Yaroslavl, 150000; 33, Lenin Ave., Yaroslavl, 150003
I. N. Solovyov
Yaroslavl State Medical University; Center for Diagnostics and Prevention Plus
Russian Federation
Russian Federation
Igor N. Solovyov - Cand. Sci. (Med.), Associate Professor of the Department of Traumatology and orthopedics, Yaroslavl State Medical University; Traumatologist-Orthopedist, Center for Diagnostics and Prevention Plus.
5, Revolutsionnaya St., Yaroslavl, 150000; 33, Lenin Ave., Yaroslavl, 150003
A. M. Gruzdev
Center for Diagnostics and Prevention Plus
Russian Federation
Russian Federation
Alexey M. Gruzdev - Ultrasound Diagnostics Doctor, Center for Diagnostics and Prevention Plus.
33, Lenin Ave., Yaroslavl, 150003
References
1. Scheuing WJ, Reginato AM, Deeb M, Acer Kasman S. The burden of osteoarthritis: Is it a rising problem? Best Pract Res Clin Rheumatol. 2023:101836. https://doi.org/10.1016/j.berh.2023.101836.
2. Molnar V, Matišić V, Kodvanj I, Bjelica R, Jeleč Ž, Hudetz D et al. Cytokines and Chemokines Involved in Osteoarthritis Pathogenesis. Int J Mol Sci. 2021;22(17):9208. https://doi.org/10.3390/ijms22179208.
3. Fioravanti A, Tenti S, Cheleschi S. Editorial: Year 2020: New Trends in Pharmacological Treatments for Osteoarthritis. Front Pharmacol. 2022;13:892934. https://doi.org/10.3389/fphar.2022.892934.
4. Ganz R, Parvizi J, Beck M, Leunig M, Nötzli H, Siebenrock KA. Femoroacetabular impingement: a cause for osteoarthritis of the hip. Clin Orthop Relat Res. 2003;(417):112–120. https://doi.org/10.1097/01.blo.0000096804.78689.c2.
5. Ganz R, Leunig M, Leunig-Ganz K, Harris WH. The etiology of osteoarthritis of the hip: an integrated mechanical concept. Clin Orthop Relat Res. 2008;466(2):264–272. https://doi.org/10.1007/s11999-007-0060-z.
6. Matsumoto K, Ganz R, Khanduja V. The history of femoroacetabular impingement. Bone Joint Res. 2020;9(9):572–577. https://doi.org/10.1302/2046-3758.99.BJR-2020-0003.
7. Lespasio MJ, Sultan AA, Piuzzi NS, Khlopas A, Husni ME, Muschler GF, Mont MA. Hip Osteoarthritis: A Primer. Perm J. 2018;22(1):17-084. https://doi.org/10.7812/TPP/17-084.
8. Sandiford N. Kendoff D, Muirhead-Allwood S. Osteoarthritis of the hip: aetiology, pathophysiology and current aspects of management. Ann Jt. 2019;5:8. https://doi.org/10.21037/aoj.2019.10.06.
9. Van Berkel AC, Schiphof D, Waarsing JH, Runhaar J, van Ochten JM, Bindels PJE, Bierma-Zeinstra SMA. Course of pain and fluctuations in pain related to suspected early hip osteoarthritis: the CHECK study. Fam Pract. 2022;39(6):1041–1048. https://doi.org/10.1093/fampra/cmac030.
10. Bothner H, Wik O. Rheology of hyaluronate. Acta Otolaryngol. 1987;104(Suppl. 442):25–30. https://doi.org/10.3109/00016488709102834.
11. Wang CT, Lin YT, Chiang BL, Lin YH, Hou SM. High molecular weight hyaluronic acid down-regulates the gene expression of osteoarthritis-associated cytokines and enzymes in fibroblast-like synoviocytes from patients with early osteoarthritis. Osteoarthritis Cartilage. 2006;14(12):1237–1247. https://doi.org/10.1016/j.joca.2006.05.009.
12. Yasuda T. Hyaluronan inhibits prostaglandin E2 production via CD44 in U937 human macrophages. Tohoku J Exp Med. 2010;220(3):229–235. https://doi.org/10.1620/tjem.220.229.
13. Sasaki A, Sasaki K, Konttinen YT, Santavirta S, Takahara M, Takei H et al. Hyaluronate inhibits the interleukin-1beta-induced expression of matrix metalloproteinase (MMP)-1 and MMP-3 in human synovial cells. Tohoku J Exp Med. 2004;204(2):99–107. https://doi.org/10.1620/tjem.204.99.
14. Тихилов РМ, Лила АМ, Кочиш АЮ, Алексеева ЛИ, Шубняков ИИ, Денисов АО. Коксартроз: клинические рекомендации. М.; 2021. 71 с. Режим доступа: https://cr.minzdrav.gov.ru/recomend/666_1.
15. Clementi D, D’Ambrosi R, Bertocco P, Bucci MS, Cardile C, Ragni P et al. Efficacy of a single intra-articular injection of ultra-high molecular weight hyaluronic acid for hip osteoarthritis: a randomized controlled study. Eur J Orthop Surg Traumatol. 2018;28(5):915–922. https://doi.org/10.1007/s00590-017-2083-9.
16. Migliore A, Tormenta S, Laganà B, Piscitelli P, Granata M, Bizzi E et al. Safety of intra-articular hip injection of hyaluronic acid products by ultrasound guidance: an open study from ANTIAGE register. Eur Rev Med Pharmacol Sci. 2013;17(13):1752–1759. Available at: https://www.europeanreview.org/article/4552.
17. Eymard F, Maillet B, Lellouche H, Mellac-Ducamp S, Brocq O, Loeuille D et al. Predictors of response to viscosupplementation in patients with hip osteoarthritis: results of a prospective, observational, multicentre, open-label, pilot study. BMC Musculoskelet Disord. 2017;18(1):3. https://doi.org/10.1186/s12891-016-1359-2.
18. Koyano G, Jinno T, Koga D, Hoshino C, Okawa A. Intra-articular Injections of Cross-linked Hyaluronic Acid in Japanese Patients with Symptomatic Osteoarthritis of the Hip. Prog Rehabil Med. 2021;6:20210038. https://doi.org/10.2490/prm.20210038.
19. Migliore A, Frediani B, Gigliucci G, Foti C, Crimaldi S, De Lucia O, Iolascon G. Efficacy of a Single Intra-Articular HYMOVIS ONE Injection for Managing Symptomatic Hip Osteoarthritis: A 12-Month Follow-Up Retrospective Analysis of the ANTIAGE Register Data. Orthop Res Rev. 2020;12:19–26. https://doi.org/10.2147/ORR.S239355.
20. Pogliacomi F, Schiavi P, Paraskevopoulos A, Leigheb M, Pedrazzini A, Ceccarelli F, Vaienti E. When is indicated viscosupplementation in hip osteoarthritis? Acta Biomed. 2018;90(Suppl. 1):67–74. Available at: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6503407/.
21. Migliore A, Massafra U, Bizzi E, Vacca F, Martin-Martin S, Granata M et al. Comparative, double-blind, controlled study of intra-articular hyaluronic acid (Hyalubrix) injections versus local anesthetic in osteoarthritis of the hip. Arthritis Res Ther. 2009;11(6):R183. https://doi.org/10.1186/ar2875.
22. Ye Y, Zhou X, Mao S, Zhang J, Lin B. Platelet rich plasma versus hyaluronic acid in patients with hip osteoarthritis: A meta-analysis of randomized controlled trials. Int J Surg. 2018;53:279–287. https://doi.org/10.1016/j.ijsu.2018.03.078.
23. Abate M, Scuccimarra T, Vanni D, Pantalone A, Salini V. Femoroacetabular impingement: is hyaluronic acid effective? Knee Surg Sports Traumatol Arthrosc. 2014;22(4):889–892. https://doi.org/10.1007/s00167-013-2581-1.
24. Lee YK, Lee GY, Lee JW, Lee E, Kang HS. Intra-Articular Injections in Patients with Femoroacetabular Impingement: a Prospective, Randomized, Double-blind, Cross-over Study. J Korean Med Sci. 2016;31(11):1822–1827. https://doi.org/10.3346/jkms.2016.31.11.1822.
25. Conrozier T, Monfort J, Chevalier X, Raman R, Richette P, Diraçoglù D et al. EUROVISCO Recommendations for Optimizing the Clinical Results of Viscosupplementation in Osteoarthritis. Cartilage. 2020;11(1):47–59. https://doi.org/10.1177/1947603518783455.
26. Filatova YuS, Solovyov IN. Hyaluronic acid in the treatment of osteoarthritis of various localization: A review. Terapevticheskii Arkhiv. 2022;94(8):1014–1019. (In Russ.) https://doi.org/10.26442/00403660.2022.08.201790.
27. Filatova YuS, Gawert VR. Intra-articular hyaluronic acid: dependence of the effect on molecular weight. RMJ. Medical Review. 2021;5(3):156–161. (In Russ.) https://doi.org/10.32364/2587-6821-2021-5-3-156-161.
28. Filatova YuS, Solovyov IN. Patients with osteoarthritis of the knee: management in the outpatient setting. Meditsinskiy Sovet. 2021;(2):86–93. (In Russ.) https://doi.org/10.21518/2079-701X-2021-2-86-93.
Review
For citations:
Filatova YS, Solovyov IN, Gruzdev AM. Osteoarthritis of the hip joints: possibilities of local therapy. Meditsinskiy sovet = Medical Council. 2023;(21):152-158. (In Russ.) https://doi.org/10.21518/ms2023-407
Views:
401
Email this article 